Polyglutamine-induced ion channels: A possible mechanism for the neurotoxicity of huntington and other CAG repeat diseases

Journal of Neuroscience Research

Volumn 60, Issue 4, 2000, Pages 490-494

  Hirakura, Yutaka ^a   Azimov, Rustam ^a,d   Azimova, Rushania ^a,d   Kagan, Bruce L ^a,b,c,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Gtr Los Angeles VA Hlthcare System   (United States)

^d Institute of Bioorganic Chemistry Uzbekistan Academy of Sciences   (Uzbekistan)

^e Uzbek Academy of Science ^*  (United States)

Author keywords

Amyloid; Ataxia; Membranes; Pores

Indexed keywords

ION CHANNEL;

ARTICLE; HUNTINGTON CHOREA; NERVE DEGENERATION; NEUROTOXICITY; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; TRINUCLEOTIDE REPEAT;

EID: 0034657229     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000515)60:4<490::AID-JNR7>3.0.CO;2-9     Document Type: Article

References (22)

1. Arispe N, Rojas E, Pollard HB. 1993. Alzheimer disease amyloid b protein forms-calcium channels in bilayer membranes: blockage by tromethamine and aluminum. Proc Natl Acad Sci USA 90:567-571.
2. Gusella JF, Persichetti F, MacDonald ME. 1997. The genetic detect causing Huntington disease: repeated in other contexts? Mol Med 3:238-246.
3. Hirakura Y, Kagan BL. 2000. The role of amyloid peptide channels in Alzheimer and other amyloidoses. Einstein Quart J Biol Med 16: (in press).
4. Hirakura Y, Lin MC, Kagan BL. 1999. Alzheimer amyloid AB1-42 channels: effects of solvent, pH, and Congo Red. J Neurosci Res 57:458-466.
5. Hirakura Y, Yiu W, Yamamoto A, Kagan BL. 2000. Amyloid peptide channels: blockade by zinc and inhibition by Congo Red. Amyloid: Int J Exp Clin Res (in press).
6. Janson J, Ashley RH, Harrison D, Mc Intyre S, Bulter PC. 1999. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate sized toxic amyloid particles. Diabetes 48:552-556.
7. Kagan BL, Selsted ME, Ganz T, Lehrer RI. 1990. Antimicrobial defensin peptides form voltage dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci USA 87:210-4.
8. Kahlem P, Terre C, Green H, Djian P. 1996. Peptides containing glutamine repeats as substrates tor transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system. Proc Natl Acad Sci USA 93:14580-14585.
9. Kim T-W, Tanzi RE. 1998. Neuronal intranuclear inclusions in polyglutamine diseases: nuclear weapons or nuclear fallout? Neuron 21:657-659.
10. Kourie JI. 1999. Synthetic mammalian C-type natriuretic peptide forms large cation channels. FEBS Lett 445:57-62
11. +2 sensitive channel in reconstituted lipid vesicles. Biochem J 38:111 89-96.
12. Lin M-C, Mirzabekov TA, Kagan BL. 1997. Channel formation by a neurotoxic prion protein fragment. J Biol Chem 272:44-47
13. Lunkes A, Mandel JL. 1997. Polyglutamines, nuclear inclusions and neurodegeneration. Nature Med 3:1201-1202.
14. Mirzabekov T, Lin M-C, Yuan W-I, Marshall PJ, Carman M, Tomaseli K, Lieberburg I, Kagan BL. 1994. Channel formation in planar lipid bilayers by a neurotoxic fragment of the beta-amyloid peptide. Biochem Biophys Res Commun 202:1142-1148.
15. Mirzabekov TA, Lin M-C, Kagan BL. 1996. Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem 271:1988-1992.
16. Mirzabekov TA, Silberstein AV, Kagan BL. 1998. The use of planar lipid bilayer membranes for rapid screening of membrane active compounds. Meth Enzymol 294:661-674.
17. Perutz M, Johnson T, Suzuki M, Finch JT. 1994. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative disease. Proc Natl Acad Sci USA 91:5355-5358.
18. Reed JC. 1997. Cytochrome c: can't live with it. Can't live without it. Cell 91:559-562.
19. 2+ sensitive channel. J Biol Chem 273:13379-13382.
20. Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, Bates GP, Davies SW, Lehrach H, Wanker EE. 1997. Huntington-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90:549-558.
21. Taylor SC, Batten TFC, Peers C. 1999. Hypoxic enhancement of quantal catecholamine secretion. Evidence for the involvement of amyloid-beta peptides. J Biol Chem 274:31217-31222.
22. Walling HW, Baldassare JJ, Westfall TC. 1998. Molecular aspects of Huntington disease. J Neurosci Res 54:301-308